Dawn Redman

Dawn Redman serves as a key procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of critical scientific, diagnostic, and operational capabilities. She manages a diverse portfolio of contracts enabling laboratory diagnostics, biomedical research, and data-driven public health responses, with a focus on securing high-performance analytical instruments, clinical testing services, and specialized technical support. Her work directly facilitates the CDC’s ability to detect, respond to, and mitigate infectious disease threats through timely and compliant acquisition processes aligned with federal procurement regulations. Redman maintains sustained relationships with leading contractors including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, and Cepheid, partnering with organizations that deliver advanced laboratory systems, infectious disease testing platforms, and public health operational support. Her contracting patterns reflect a preference for established industry leaders with proven expertise in biosafety-compliant services and FDA-cleared diagnostic technologies, while also integrating smaller firms capable of rapid-scale deployment in emergency response scenarios. Her procurement strategy prioritizes broad market access, with 65% of awards issued as unrestricted competitions, yet she actively promotes socioeconomic inclusion through consistent use of Small Business Set-Asides (13%), Women-Owned Small Business set-asides (13%), and targeted HUBZone and 8(a) opportunities (4.3% each). This balanced approach ensures competitive rigor while advancing equitable participation across the public health supply chain. Her primary NAICS focus includes Medical Laboratories (621511), All Other Professional, Scientific, and Technical Services (541990), and Analytical Laboratory Instrument Manufacturing (334516), reflecting deep expertise in procuring clinical diagnostics, epidemiological data systems, and precision instrumentation for biosurveillance. She specializes in acquiring complex, high-integrity solutions that meet stringent federal biosafety and data integrity standards.